We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lactate Analyzer with POC Hematocrit Compensation Launched

By LabMedica International staff writers
Posted on 10 Dec 2013
A lactate analyzer, originally developed for coaches and sportsmen, has additional features that make it suitable for further medical applications. More...


Launched by EKF Diagnostics (Cardiff, United Kingdom), the upgraded Lactate Scout+ includes built-in hematocrit compensation. This makes it suitable for a range of medical applications including cord blood lactate (CBL) analysis that can give a picture of acid-base balance at birth and is particularly recommended after high risk deliveries, fetal scalp lactate (FSL), that can be used to confirm abnormal cardiotocography values and helps to determine the need for immediate intervention in complicated births where there may be risk of insufficient fetal oxygen supply.

The in-built compensation for hematocrit (Hct) within Lactate Scout+ ensures accurate lactate measurements even at high (>50%) or low (<35%) Hct levels. The new analyzer’s Hct range is 20%–70%, which means patients with either very low Hct levels (e.g., after blood loss) or very high levels (e.g., professional athletes and neonates) can be accurately assessed. This makes Lactate Scout+ ideal for a range of medical applications. These include cardio training, weight reduction, and fitness applications which are already well established, as well as new applications in obstetrics.

EKF CEO, Julian Baines commented, “The launch of the new version of Lactate Scout+ reaffirms EKF Diagnostics’ long term expertise in lactate measurement.”

Related Links:

EKF Diagnostics



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.